Barinthus Biotherapeutics PLC
NASDAQ:BRNS

Watchlist Manager
Barinthus Biotherapeutics PLC Logo
Barinthus Biotherapeutics PLC
NASDAQ:BRNS
Watchlist
Price: 0.73 USD 1.21%
Market Cap: 29.8m USD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of BRNS.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BRNS Intrinsic Value
Not Available
Base Case Scenario
Compare BRNS to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about BRNS?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Barinthus Biotherapeutics PLC

Current Assets 86.8m
Cash & Short-Term Investments 74.3m
Receivables 4.9m
Other Current Assets 7.6m
Non-Current Assets 22.4m
PP&E 6.6m
Intangibles 14.9m
Other Non-Current Assets 929k
Current Liabilities 10.8m
Accounts Payable 698k
Accrued Liabilities 8.7m
Other Current Liabilities 1.4m
Non-Current Liabilities 13.9m
Other Non-Current Liabilities 13.9m
Efficiency

Free Cash Flow Analysis
Barinthus Biotherapeutics PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Barinthus Biotherapeutics PLC

Revenue
0 USD
Operating Expenses
-42.2m USD
Operating Income
-42.2m USD
Other Expenses
-12.6m USD
Net Income
-54.8m USD
Fundamental Scores

BRNS Profitability Score
Profitability Due Diligence

Barinthus Biotherapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Negative 3Y Average Net Margin
Negative 3Y Average Operating Margin
Declining ROE
hidden
Profitability
Score

Barinthus Biotherapeutics PLC's profitability score is hidden . The higher the profitability score, the more profitable the company is.

BRNS Solvency Score
Solvency Due Diligence

Barinthus Biotherapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
hidden
Solvency
Score

Barinthus Biotherapeutics PLC's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BRNS Price Targets Summary
Barinthus Biotherapeutics PLC

Wall Street analysts forecast BRNS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BRNS is 5.1 USD with a low forecast of 3.03 USD and a high forecast of 7.35 USD.

Lowest
Price Target
3.03 USD
315% Upside
Average
Price Target
5.1 USD
599% Upside
Highest
Price Target
7.35 USD
907% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Barinthus Biotherapeutics PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for BRNS is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y